Literature DB >> 10851051

JAK-STAT signaling activated by Abl oncogenes.

N N Danial1, P Rothman.   

Abstract

The Abl oncoproteins v-Abl and BCR-Abl can activate member of the signal transducers and activators of transcription (STAT) family of signaling proteins. The mechanisms by which these oncoproteins activate STATs appear to differ. In cells transformed by v-Abl, Janus kinase (JAK) tyrosine kinases are constitutively activated. In these cells, the v-Abl oncoprotein and the JAK kinases physically associate. Mapping of the JAK interaction domain in v-Abl demonstrates that amino acids within the carboxyl terminal region of v-Abl bind JAKs through a direct interaction. A mutant of v-Abl lacking this region does not bind or activate JAK 1 in vivo, fails to activate STAT proteins, does not induce cellular proliferation, and is less efficient in cellular transformation. Kinase inactive mutants of JAK 1 inhibit the ability of v-Abl to activate STATs, to induce cytokine-independent proliferation, and to transform bone marrow cells. Interestingly, these effects correlate with defects in the activation of several pathways by v-Abl including Akt, PI3-kinase, STATs, and Ras. These data suggest that Jak kinases may play an important role in v-Abl induced transformation. Oncogene (2000).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10851051     DOI: 10.1038/sj.onc.1203484

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  43 in total

1.  Expression of a Src family kinase in chronic myelogenous leukemia cells induces resistance to imatinib in a kinase-dependent manner.

Authors:  Teodora Pene-Dumitrescu; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  Activation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells.

Authors:  Geoffrey A Bartholomeusz; Moshe Talpaz; Vaibhav Kapuria; Ling Yuan Kong; Shimei Wang; Zeev Estrov; Waldemar Priebe; Ji Wu; Nicholas J Donato
Journal:  Blood       Date:  2007-01-03       Impact factor: 22.113

3.  Transcription and signalling pathways involved in BCR-ABL-mediated misregulation of 24p3 and 24p3R.

Authors:  Zhi Sheng; Shu-Zong Wang; Michael R Green
Journal:  EMBO J       Date:  2009-02-19       Impact factor: 11.598

4.  NESH protein expression switches to the adverse effect of imatinib mesylate.

Authors:  Satoru Matsuda; Yasukatu Ichigotani; Naoko Okumura; Hitomi Yoshida; Yuka Kajiya; Yasuko Kitagishi; Naoki Shirafuji
Journal:  Mol Oncol       Date:  2008-03-20       Impact factor: 6.603

5.  Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation.

Authors:  Xianping Shi; Xin Chen; Xiaofen Li; Xiaoying Lan; Chong Zhao; Shouting Liu; Hongbiao Huang; Ningning Liu; Siyan Liao; Wenbin Song; Ping Zhou; Shunqing Wang; Li Xu; Xuejun Wang; Q Ping Dou; Jinbao Liu
Journal:  Clin Cancer Res       Date:  2013-12-12       Impact factor: 12.531

6.  Chromium(VI) stimulates Fyn to initiate innate immune gene induction in human airway epithelial cells.

Authors:  Antonia A Nemec; Lindsey M Zubritsky; Aaron Barchowsky
Journal:  Chem Res Toxicol       Date:  2010-02-15       Impact factor: 3.739

7.  BCR-ABL suppresses autophagy through ATF5-mediated regulation of mTOR transcription.

Authors:  Zhi Sheng; Leyuan Ma; Jiaoyuan E Sun; Lihua J Zhu; Michael R Green
Journal:  Blood       Date:  2011-06-29       Impact factor: 22.113

8.  Phosphatidic Acid Increases Epidermal Growth Factor Receptor Expression by Stabilizing mRNA Decay and by Inhibiting Lysosomal and Proteasomal Degradation of the Internalized Receptor.

Authors:  Nathaniel Hatton; Erin Lintz; Madhu Mahankali; Karen M Henkels; Julian Gomez-Cambronero
Journal:  Mol Cell Biol       Date:  2015-06-29       Impact factor: 4.272

9.  Absence of p53 complements defects in Abelson murine leukemia virus signaling.

Authors:  Indira Unnikrishnan; Naomi Rosenberg
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  Inhibition of mitochondrial metabolism by methyl-2-cyano-3,12-dioxooleana-1,9-diene-28-oate induces apoptotic or autophagic cell death in chronic myeloid leukemia cells.

Authors:  Ismael Samudio; Svitlana Kurinna; Peter Ruvolo; Borys Korchin; Hagop Kantarjian; Miloslav Beran; Kenneth Dunner; Seiji Kondo; Michael Andreeff; Marina Konopleva
Journal:  Mol Cancer Ther       Date:  2008-05       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.